These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36847831)

  • 1. The effect of SSRIs on fear learning: a systematic review and meta-analysis.
    Heesbeen EJ; Bijlsma EY; Verdouw PM; van Lissa C; Hooijmans C; Groenink L
    Psychopharmacology (Berl); 2023 Nov; 240(11):2335-2359. PubMed ID: 36847831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits.
    Burghardt NS; Bauer EP
    Neuroscience; 2013 Sep; 247():253-72. PubMed ID: 23732229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSRIs and conditioned fear.
    Inoue T; Kitaichi Y; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1810-9. PubMed ID: 21925230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of SSRIs on unconditioned anxiety: a systematic review and meta-analysis of animal studies.
    Heesbeen EJ; van Kampen T; Verdouw PM; van Lissa C; Bijlsma EY; Groenink L
    Psychopharmacology (Berl); 2024 Jul; ():. PubMed ID: 38980348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological basis of anxiety disorders and serotonergic anxiolytics].
    Inoue T; Izumi T; Li XB; Huang JZ; Kitaichi Y; Nakagawa S; Koyama T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):125-31. PubMed ID: 15291241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram reversed the traumatic stress-induced depressed and anxiety-like symptoms but not the deficits of fear memory.
    Lin CC; Tung CS; Liu YP
    Psychopharmacology (Berl); 2016 Apr; 233(7):1135-46. PubMed ID: 26740318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis.
    Fluyau D; Mitra P; Jain A; Kailasam VK; Pierre CG
    Eur J Clin Pharmacol; 2022 Jun; 78(6):931-942. PubMed ID: 35246699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Zohar J; Westenberg HG
    Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety.
    Kent JM; Coplan JD; Gorman JM
    Biol Psychiatry; 1998 Nov; 44(9):812-24. PubMed ID: 9807637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.
    Vaswani M; Linda FK; Ramesh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):85-102. PubMed ID: 12551730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors].
    Yamauchi M; Hiraoka S; Imanishi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):193-8. PubMed ID: 17240844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
    Mead GE; Hsieh CF; Lee R; Kutlubaev MA; Claxton A; Hankey GJ; Hackett ML
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD009286. PubMed ID: 23152272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist.
    Burghardt NS; Bush DE; McEwen BS; LeDoux JE
    Biol Psychiatry; 2007 Nov; 62(10):1111-8. PubMed ID: 17524369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
    Strawn JR; Mills JA; Sauley BA; Welge JA
    J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Melatonergic System in Anxiety Disorders and the Role of Melatonin in Conditional Fear.
    Huang F; Yang Z; Li CQ
    Vitam Horm; 2017; 103():281-294. PubMed ID: 28061973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinction.
    Lebrón-Milad K; Tsareva A; Ahmed N; Milad MR
    Behav Brain Res; 2013 Sep; 253():217-22. PubMed ID: 23886596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Dorsal Raphe Nucleus Serotonergic Systems in Emotional Learning and Memory in Male BALB/c Mice.
    Payet JM; Stevens L; Russo AM; Jaehne EJ; van den Buuse M; Kent S; Lowry CA; Baratta MV; Hale MW
    Neuroscience; 2023 Dec; 534():1-15. PubMed ID: 37852412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anxiety disorder].
    Inoue T; Koyama T
    Brain Nerve; 2012 Feb; 64(2):131-8. PubMed ID: 22308258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.